This New Drug Could Help End the HIV Epidemic—but US Funding Cuts Are Killing Its Rollout
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...
Don’t drop the ball on HIV/Aids, says scientist
KZN’s top women researcher believes a game changer is around the corner. It needs political will and no geopolitical head winds ...
US aid freeze puts HIV-positive orphans in Kenya at risk as medical supplies dwindle
Two-year-old Evans was brought to the Nyumbani Children’s Home in Nairobi, Kenya a year ago, suffering from HIV and ...
unaids2d
UNAIDS launches the development of the new Global AIDS Strategy 2026-2031
This is why UNAIDS is launching the development of the new Global AIDS Strategy 2026-2031, an ambitious, inclusive, and action-driven plan that will guide the global HIV response for the next five ...
Science Daily2d
New therapy may effectively control HIV in Uganda
A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.
BMJ2d
Climate footprint of industry-sponsored in-human clinical trials: life cycle assessments of clinical trials spanning multiple phases and disease areas
According to the definitions of the Life Cycle Initiative,13 the foreground system consists ... to the previously published LCA results for the TMC114FD1HTX1002 phase 1 HIV trial, we see some more ...
Drug therapy lenacapavir may effectively control HIV in Uganda
A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...
News Medical3d
New HIV therapy lenacapavir shows high efficacy in Ugandan population
A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...
Gilead Gets FDA Priority Review of Twice-Yearly Shot to Prevent HIV
Gilead Sciences has won Food and Drug Administration priority review for its proposed lenacapavir twice-yearly shot to prevent HIV. Gilead on Tuesday said an FDA green light would make lenacapavir the ...
HIV protein switch may help virus squeeze into host cell nucleus
Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its ...
Rolling Out5d
Silent warning signs of HIV you’re likely dismissing
From persistent fevers to unexplained weight loss, discover the subtle HIV symptoms doctors say you shouldn't ignore, ...